Abstract:Background: Longitudinal T1 relaxation time is a key imaging biomarker. In addition, T1 values are modulated by the administration of T1 contrast agents used in patients with tumors and metastases. However, in clinical practice, dedicated T1 mapping sequences are often not included in brain MRI protocols. The aim of this study is to address the absence of dedicated T1 mapping sequences in imaging protocol by deriving T1 maps from standard T1-weighted sequences. Methods: A phantom, composed of 144 solutions of paramagnetic agents at different concentrations, was imaged with a three-dimensional (3D) T1-weighed turbo spin-echo (TSE) sequence designed for brain imaging. The relationship between the T1 values and the signal intensities was established using this phantom acquisition. T1 mapping derived from 3D T1-weighted TSE acquisitions in four healthy volunteers and one patient with brain metastases were established and compared to reference T1 mapping technique. The concentration of Gd-based contrast agents in brain metastases were assessed from the derived T1 maps. Results: Based on the phantom acquisition, the relationship between T1 values and signal intensity (SI) was found equal to T1 = 0.35 × SI-1.11 (R2 = 0.97). TSE-derived T1 values measured in white matter and gray matter in healthy volunteers were equal to 0.997 ± 0.096 s and 1.358 ± 0.056 s (mean ± standard deviation), respectively. Mean Gd3+ concentration value in brain metastases was 94.7 ± 30.0 μM. Conclusion: The in vivo results support the relevance of the phantom-based approach: brain T1 maps can be derived from T1-weighted acquisitions. Relevance statement: High-resolution brain T1 maps can be generated, and contrast agent concentration can be quantified and imaged in brain metastases using routine 3D T1-weighted TSE acquisitions. Key points: Quantitative T1 mapping adds significant value to MRI diagnostics. T1 measurement sequences are rarely included in routine protocols. T1 mapping and concentration of contrast agents can be derived from routine standard scans. The diagnostic value of MRI can be improved without additional scan time.

Assessment of accuracy and repeatability of quantitative parameter mapping in MRI

Abstract WP292: Quantitative Susceptibility Mapping for Reliably Measuring Hematoma Volume in Magnetic Resonance Imaging

Three-dimensional Simultaneous Brain Mapping of T1, T2, T2*and Magnetic Susceptibility with MR Multitasking

Hematoma Volume Measurement in Gradient Echo MRI Using Quantitative Susceptibility Mapping.

Quantitative multi-parameter mapping of R1, PD, MT, and R2 at 3T: a multi-center validation

A novel myocardial T1 analysis method robust to fluctuations in longitudinal magnetization recovery due to heart rate variability in polarity-corrected inversion time preparation

Brain Parcellation Repeatability and Reproducibility Using Conventional and Quantitative 3D MR Imaging

Repeatability and Accuracy of MR-STAT Quantitative T1 and T2 Measurements

Repeat it without me: Crowdsourcing the T1 mapping common ground via the ISMRM reproducibility challenge

Cross‐vendor multiparametric mapping of the human brain using 3D‐QALAS: A multicenter and multivendor study

A quantitative multi-parameter mapping protocol standardized for clinical research in autoimmune neuroinflammatory diseases with white matter abnormalities

Single-point macromolecular proton fraction mapping using a 0.3 T permanent magnet MRI system: phantom and healthy volunteer study

Quantitative Parametric Mapping of Tissues Properties from Standard Magnetic Resonance Imaging Enabled by Deep Learning

New efforts to quantitative T2-mapping imaging.

Comparison study of quantitative susceptibility mapping with GRAPPA and wave-CAIPI: reproducibility, consistency, and microbleeds detection

Verification of Quantification of Quantitative Susceptibility Mapping for Estimating the Amount of Gadolinium Deposited in the Brain: a Preliminary Phantom Study

Approximating R1 and R2: a quantitative approach to clinical weighted MRI

Effects of prospective motion correction on perivascular spaces at 7T MRI evaluated using motion artifact simulation

Magnetic resonance biomarker assessment software (MR-BIAS): an automated open-source tool for the ISMRM/NIST system phantom

Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials – A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study

Quantitative brain T1 maps derived from T1-weighted MRI acquisitions: a proof-of-concept study